CytoMed Therapeutics Limited Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $2.12 | $2.12 | $2.12 |
| Q2 2024 | 0 | $1.81 | $1.81 | $1.81 |
| Q3 2024 | 0 | $1.98 | $1.98 | $1.98 |
CytoMed Therapeutics Limited Earnings Date And Information
CytoMed Therapeutics Limited last posted its earnings results on N/A. The company reported $N/A earnings per share for the quarter, missing analysts' consensus estimates of $N/A by $0. The company had revenue of 84,685 for the quarter and had revenue of 384,747 for the year. CytoMed Therapeutics Limited has generated $0 earnings per share over the last year ($-0.29 diluted earnings per share) and currently has a price-to-earnings ratio of -3.93. CytoMed Therapeutics Limited has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
CytoMed Therapeutics Limited Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/22/2024 | Q4 2023 | -$0.13 | $84,685 | $84,685 | ||
| 09/29/2023 | Q3 2023 | -$0.06 | $0 | $81,747 | ||
| 06/28/2023 | Q2 2023 | -$0.14 | $121,831 | $105,084 | ||
| 03/30/2023 | Q1 2023 | -$0.08 | $106,785 | |||
| 05/01/2023 | Q4 2022 | -$0.14 | $108,021 | |||
| 09/29/2022 | Q3 2022 | -$0.09 | $100,740 | |||
| 06/28/2022 | Q2 2022 | -$0.00 | $0 | |||
| 12/29/2021 | Q4 2021 | $0.00 | $0 | |||
| 06/28/2021 | Q2 2021 | -$0.00 | $0 |
CytoMed Therapeutics Limited Earnings: Frequently Asked Questions
-
When is CytoMed Therapeutics Limited's earnings date?
CytoMed Therapeutics Limited has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based off last year's report dates.
-
How can I listen to CytoMed Therapeutics Limited's earnings conference call?
The conference call for CytoMed Therapeutics Limited's latest earnings report can be listened to online.
-
How can I read CytoMed Therapeutics Limited's conference call transcript?
The conference call transcript for CytoMed Therapeutics Limited's latest earnings report can be read online.
-
How much revenue does CytoMed Therapeutics Limited generate each year?
CytoMed Therapeutics Limited (:GDTC) has a recorded annual revenue of $384,747.
-
How much profit does CytoMed Therapeutics Limited generate each year?
CytoMed Therapeutics Limited (:GDTC) has a recorded net income of $384,747. CytoMed Therapeutics Limited has generated $-0.29 earnings per share over the last four quarters.
-
What is CytoMed Therapeutics Limited's price-to-earnings ratio?
CytoMed Therapeutics Limited (:GDTC) has a price-to-earnings ratio of -3.93 and price/earnings-to-growth ratio is -0.13.
